Additionally, this upregulation of VIM in MIA PaCa-2 was also significant compared to H treatment group, confirming that there exist specific contributions to invasive tumor cell phenotypes that derive from hypoxic stellate cells. This evidence concerns the gene VIM and neoplasm.